Google and Microsoft's new WebMCP standard lets websites expose callable tools to AI agents through the browser — replacing costly scraping with structured function calls.
Opinion
The Register on MSNOpinion
When AI 'builds a browser,' check the repo before believing the hype
Autonomous agents may generate millions of lines of code, but shipping software is another matter Opinion AI-integrated development environment (IDE) company Cursor recently implied it had built a ...
There is a lot of enterprise data trapped in PDF documents. To be sure, gen AI tools have been able to ingest and analyze PDFs, but accuracy, time and cost have been less than ideal. New technology ...
Parse Biosciences co-founders are CTO Charles Roco and CEO Alex Rosenberg. (Parse Photo) Seattle’s Parse Biosciences is teed up for an acquisition by Qiagen, a Netherlands-based holding company, in a ...
Parse’s Evercode enables researchers to profile gene expression in individual cells at scale. 10x Genomics had already helped to establish the single-cell sequencing market when Parse launched in 2018 ...
This story has been updated to include comments from a call with investors held on Wednesday morning. NEW YORK – Qiagen announced Tuesday that it will acquire single-cell sample preparation firm Parse ...
Parse Biosciences Inc. convinced a federal judge to invalidate one of four patents covering single-cell sequencing technology that Roche Holding AG licensed to Scale Biosciences Inc., narrowing the ...
A JSON parse error happens when software cannot read a JSON file due to incorrect formatting or unexpected tokens. This guide shows how to identify the issue and ...
This README is an AI-generated document. Details are mostly accurate but might include inaccurate description. Browser Support: Browser compatibility is only available through the npm package. The JSR ...
10x Genomics (NASDAQ:TXG) announced on Monday that its ATAC-Seq patents were found valid and infringed in its patent litigation with Parse Biosciences. On February 25, 2025, a consent agreement was ...
PLEASANTON, Calif., March 3, 2025 /PRNewswire/ -- 10x Genomics (Nasdaq: TXG), a leader in single-cell and spatial biology, today provided an update on its patent litigation with Parse Biosciences.
A federal judge canceled a looming jury trial in 10x Genomics Inc.’s case against Parse Biosciences Inc. over patented cell-analysis technology, pausing the suit while 10x appeals the invalidation of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results